Acutaas Chemicals Ltd · NSE:ACUTAAS
Acutaas Chemicals — Q1 FY26 Earnings Presentation
12 slides from Acutaas Chemicals's earnings presentation, Jul 30, 2025
Slide 1: Acutaas Chemicals Limited – Investor Presentation Filing
B ACUTAAS CHEMICALS LIMITED A (Formerly known as Ami Organics Limited) CIN No. : L24100GJ2007PLC051093 You and us: chemistry’s apex July 30, 2025 To, To, The Listing Department, The Listing Department BSE LIMITED, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, 5
Slide 2: Earnings Presentation
A A ACUIAAS EARNINGS PRESENTATION 22222222 \\\\\\\§
Slide 3: Management Commentary
Management Commentary You and us chamistrys apex Executive Chairman and Managing Director “I am happyto share that we've had a strong start to FY26, with Q1 revenue growing 17.3% vyear-on-year, driven by robust performance in our Pharmaceutical Intermediates business. Both our pharma facilities are
Slide 4: Revenue to PAT Bridge
Revenue to PAT Bridge ACUTAAS You and s chomisn’s pex Q 1 2,072 FY26 -969 | 251 159 581 [ e 428 — — 440 Revenue COGS Gross Employee Other EBITDA D&A PBIT Finance Other PBT Tax PAT from Profit Cost expenses costs Income Expense Operations 53.2% 24.6% 21.2% 1,767 743 FY25 -1,023 . ETT | 205 233 - o0 s
Slide 5: Q1 FY26 Financial Performance — Key Metrics
Q1 FY26 Financial Performance — Key Metrics ACUTAAS You and us chemistrys apex Revenue from Operations (Mn) Q1 FY26 Earnings & Business Highlights YoY Growth 23.3% (1.8%) 17.3% > 2,072 Robust growth in Advanced Pharmaceutical Intermediates supported overall revenue, with specialty chemicals business
Slide 6: Q1 FY26 Financial Performance — P&L Statement
lQ1 FY26 Financial Performance — P&L Statement actass You and us chemistrys apex Particulars (¥ YoY Q4FY25 QoQ FY25 FY24 YoY Revenue from Operations 2,072 1,767 17.3% 3,085 -32.8% 10,069 7,75 40.3% COGS 969 1023 1625 5,522 4117 Gross Profit (A) 1,103 743 48.4% 1,460 -24.4% 4,547 3,058 48.7% Gross Ma
Slide 7: Financial Performance over the years — Key Metrics
Financial Performance over the years — Key Metrics AcUians You and us chemistrys apex Revenue from Operations- Growth Trends (FMn.) EBITDA and EBITDA Margins (FMn. & %) FY20-25 CAGR: m— EBITDA ( Mn) —e—EBITDA Margin (%) 29.8% 83.3% 33.3% = 23.5% 23.0% g FY19 =FY20 mFY21 mFY22 mFY23 mFY24 mFY25 20.2%
Slide 8: Financial Performance over the years - Profit and Loss
Financial Performance over the years - Profit and Loss AcUians You and us chemistrys apex culars (Z Mn.) 21 FY22 FY23 FY24 FY25 Revenue from Operations 3,406 5,201 6,167 7175 10,069 Other Income 14 28 43 75 169 Total Income 3,420 5,229 6,210 7,250 10,238 Cost of materials consumed 1,749 2,823 3,459
Slide 9: Financial Performance over the years - Balance Sheet
Financial Performance over the years - Balance Sheet ACUTAAS You and us chemisirys cpex Assets (ZMn.) FY21 FY22 FY23 FY24 FY25 [l Equity and Liabilities (Z Mn.) FY21 FY22 FY23 FY24 FY25 Property, plant and equipment 1,422 1,584 1,844 3229 4,629 Shareholder's equity 1,669 5223 5939 6,828 13,201 Right
Slide 10: Shareholder Information
Shareholder Information ACUTAAS Shareholding as on 30" June 2025 Share Information as on 30 June 2025 Others Promoters 28 5% 32.7% NSE Tick e ACUTAAS BSE Ticker 543349 Market Cap (Rs. Cr.) 9,369 Shares Outstanding 8,18,68,922 3M ADTV (Shares) 4,94,590 3M ADTV (Rs. Cr) 64.7 Fil m MF 0, ! °/ Industry
Slide 11: Safe Harbor
Safe Harbor Acu/AT\AAs You and us chemistrys apex The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation.The information contained herein is for general information purposes only and based on estimates and should not be con
Slide 12: Contact Us
A ACUTAAS You and us: chemistry’s apex Contact Us For more information please contact: Acutaas Chemicals Limited Ekta Srivastava Company Secretary & Compliance Officer Cs @acutaascom Rahul Thakur Senior Manager - Investor Relations Rahul.thakur@acutaas.com %/ www.acutaas.com